Health News
Closing the Heart Attack Gap
Heart attack care for Asian Americans has been lacking. In recent years a new report shows substantial improvements in care have helped level the playing field in ensuring Asians receive adequate care.
Emergency CPR Coaching Saves Lives
Bystanders are often willing to help those who suddenly go into cardiac arrest, but individuals without CPR training are often reluctant to assist. Encouraging 9-1-1 dispatchers to offer assistance could increase survival.
Grieving Your Way to a Heart Attack?
The pain may be unbearable after losing a loved one. It also may be dangerous to your health. During the initial days after a close loved one dies, your risk of a heart attack is increased significantly.
Heart Attacks Are Harder
Patients aren't always out of the woods after hospital release following a heart attack. Many are readmitted later the same month after complications. Americans may be at a higher risk of readmission as compared to Canadian and European patients.
Too Much of a Good Thing
Though many people are deficient in vitamin D, it's possible to go too far to make up the difference. The "sunshine vitamin" may only protect the heart if you have the right amount.
Taking a Team Approach to Treatment
Chronic disorders impact millions of Americans. Treatment can sometimes be expensive, persistent, and ineffective. Recent research shows that a team approach to care can offer benefits.
A Healthy Brain Freeze
After a heart attack, therapeutic hypothermia lowers the risk of brain damage, but the procedure is seldom used. Moreover, this procedure saves lives and delivers positive financial results.
Aspirin Bad For Eyes?
An aspirin a day may help keep heart disease at bay, but it may also contribute to age-related macular degeneration, or gradual vision loss, according to a new study from Europe.
New Application for Bayer Heart Drug
Bayer’s cooperation partner, Janssen Research & Development, L.L.C. has submitted a Supplemental New Drug Application ( sNDA ) to the U.S. Food and Drug Administration (FDA) for the oral anticoagulant Xarelto ( rivaroxaban ) in combination with standard antiplatelet therapy to reduce the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS).
The RA Heart Left Unprotected
The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.